Tissue Regenix Group plc (LON:TRX – Get Free Report) shares crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 50.97 ($0.68) and traded as low as GBX 33 ($0.44). Tissue Regenix Group shares last traded at GBX 34.16 ($0.46), with a volume of 68,688 shares changing hands.
Tissue Regenix Group Stock Performance
The business’s fifty day simple moving average is GBX 38.88 and its 200-day simple moving average is GBX 50.97. The firm has a market cap of £31.55 million, a P/E ratio of -36.13 and a beta of 1.61. The company has a current ratio of 4.03, a quick ratio of 2.36 and a debt-to-equity ratio of 31.16.
About Tissue Regenix Group
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
See Also
- Five stocks we like better than Tissue Regenix Group
- How to trade penny stocks: A step-by-step guide
- Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet
- What Are Earnings Reports?
- Coca-Cola Company Stock Can Bubble to New Highs This Year
- Pros And Cons Of Monthly Dividend Stocks
- 3 Stocks Lifting 2025 Guidance Despite Market Jitters
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
